β-Blocker Use Is Associated With Reduced Mortality/Morbidity in Patients With HFrEF and Advanced Chronic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Circulation: Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease
Circ Heart Fail 2020 Oct 19;[EPub Ahead of Print], EL Fu, A Uijl, FW Dekker, LH Lund, G Savarese, JJ CarreroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.